ClinicalTrials.gg
RecruitingNCT07145307Updated Nov 18, 2026

Personalized Digital Treatment for Adolescent Anxiety: A Feasibility Trial

An interventional study of Sidekick in Anxiety Disorders, sponsored by Helse Stavanger HF. Recruiting at 2 sites in Norway. Open to participants aged 13 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Helse Stavanger HF · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year 1 month later.
Updated Nov 18, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Not applicable
Ages
13 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 92 studies in Anxiety Disorders with a site in Norway — 22 open to participants now, 32 under way, none of them phase 3. Anxiety Disorders · Norway.

Planned enrollment
60th of 72
46 · median 155
Started
2025
with 8 others
No phase
63 of 92
19 open now
Primary completion
2027-04
later than 18 of 31 live
Registered
83rd of 92
by date
Lead sponsor
3 of 92
Helse Stavanger HF

Among the 92 studies in Anxiety Disorders with a site in Norway, this one is the 60th largest by planned enrollment of the 72 interventional ones that give a count, is one of 9 that started in 2025, is one of 63 with no phase, reaches primary completion later than 18 of the 31 other live ones, and was the 83rd registered.

Anxiety Disorders

7,249 studies on the registry are indexed under Anxiety Disorders; 1,691 are open to participants now.

Browse Anxiety Disorders studies →

Open to participants now

22 of the 92 studies in Anxiety Disorders with a site in Norway are open now. Recruiting first, the newest first:

16 more — sign in →

All 22 open studies →

A study can be open while its sites in Norway have not opened yet or have stopped. Only those recruiting at a site in Norway →

Who these studies take

Of the 947 Anxiety Disorders studies recruiting now, 423 (45%) set no upper age limit and 455 (48%) stop at 75 or younger; 233 take children under 18; 319 take healthy volunteers.

This study: 13 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 92 studies in Anxiety Disorders with a site in Norway, or all of them as a file.
02

Study summary

The goal of this feasibility study is to test whether a new blended digital intervention for adolescents with anxiety disorders is feasible and acceptable for use, and to help plan future larger scale studies. The main questions it aims to answer are:

  • A: Can the investigators recruit appropriate participants?
  • B: How appropriate are the data collection procedures and outcome measures?
  • C: Are the study procedures and interventions suitable for and acceptable to the participants?
  • D: Does the research team have the resources and ability to manage the study and intervention?
  • E: Does the intervention show promise of being successful for adolescents with anxiety disorders?

Participants will:

  • Receive outpatient anxiety treatment, typically every other week or weekly.
  • Use the Sidekick app as a homework supplement to plan, carry out, and evaluate exposure exercises between treatment sessions.
  • Complete questionnaires before, during, after, and three months after using the app.
  • Some participants and therapists will be invited to take part in qualitative interviews following the intervention.
Read the detailed description
  1. Study goals and objectives

    This project will investigate the feasibility of an app-facilitated exposure therapy for adolescents with anxiety. The primary objective is to contribute to the development of an efficient and personalized digital treatment. To meet this objective, the project aims i) evaluate the feasibility of Sidekick, a personalized digital treatment tool for patients with anxiety disorders, and ii) evaluate the user experience of digitally assisted exposure therapy on patient-clinician dyads.

    1.1 Short-term and long-term goals

    In the short-term, this project will implement an open, explorative trial of Sidekick in specialized clinical practice. In the long-term, the project will report, communicate and implement findings in clinical and user settings. If results indicate that the blended intervention is feasible and acceptable, the next step is to seek funding and perform a large-scale, national randomized controlled trials (RCT) of a blended treatment protocol for anxiety in adolescents.

  2. Feasibility

2.1 Study design, choice of methodology and analysis

To meet the goals of this project, the investigators will conduct a single-arm feasibility trial of the app Sidekick in a blended intervention for anxiety disorders in adolescents. The open trial will include data from patients and their clinicians. The study will provide feasibility insights, determining the practicality of implementing the tool within the outpatient clinic. It will highlight usability and acceptance, as well as preliminary effectiveness of the app. User and therapist feedback will give insight into perceived benefits, challenges and suggestions for improvement, allowing for improved therapeutic options for adolescents with anxiety. The feasibility method and outcomes will be guided by Orsmond and Cohn "The Distinctive Features of a Feasibility Study: Objectives and Guiding Questions", and in line with the objectives, outcomes and interpretations of feasibility from Abbott and colleagues. Orsmond and Cohns highlights five objectives (A-E) that will be used as a template for assessing feasibility in our study. Our method for collecting data include questionnaires and user-data in the app from the patients, and qualitative interviews with both patients and clinicians. All outcomes will be reported in line with the CONSORT 2010 statement: extension to randomised pilot and feasibility trials, with adaptations to apply to our non-randomized feasibility trial.

2.1.1. Recruitment

The project aims to recruit 30 adolescents aged 13-18 from child and adolescent mental health services who, along with their clinicians, are willing to participate in the intervention as part of their treatment plan. All patient recruitment will be done in Helse Stavanger. The adolescents will receive gift cards of 250 NOK post assessment, and at 3-month follow-up. The adolescents that participate in qualitative interviews will receive an additional gift card of 250 NOK for their participation. Recruitment is set to begin in August 2025, with expected completion by the summer of 2026.

2.1.3 Procedures

Participants will first undergo a baseline assessment and be given guidance on how to use the Sidekick app to support anxiety exposure therapy. During the study period, all patients will be followed up through regular treatment at the Child and Adolescent Psychiatry Unit (BUP), which is usually weekly or bi-weekly. Patient responsibility and readiness will be maintained through this provider relationship as in regular treatment, but patients will also be provided with contact details for research personnel, who can then contact providers for the patients participating in the project. Exposure will mainly take place between treatment sessions, at times chosen by the youth themselves, or in collaboration with their clinician. Participants will undergo a baseline assessment online using the Youwell platform which is authorized for this purpose by Helse Vest. The assessment will be conducted at three timepoints: at baseline, at the end of treatment, and three months post-treatment. The feasibility and preliminary clinical outcomes of the intervention will be evaluated using quantitative methods before, during, and after the treatment. Additionally, qualitative interviews with therapists and patients will be conducted following the treatment to gather in-depth insights.

2.1.4 Interview guide

An interview guide will be used to gather data on participants' experiences, including perceived treatment. The interview guide will be developed in collaboration with users, and the interview is estimated to take 30 minutes to complete. Audio will be recorded using the app "Nettskjemadiktafon", which ensures safe storage of sensitive data. All data will be stored in TSD (in Norwegian, Service for Sensitive Data). The TSD service is designed for storing and post-processing sensitive data in compliance with the Norwegian "Personal Data Act" and "Health Research Act". Audio will be automatically transcribed using the service "Autotekst", and then manually checked by the PhD candidate.

2.1.5 Statistical analysis plan

As a feasibility study, no formal hypothesis testing will be conducted. Descriptive statistics will be used to summarize recruitment rates, retention rates, adherence, and data completeness to assess feasibility outcomes. Confidence intervals will be provided to estimate precision of feasibility parameters. Preliminary outcome measures will be explored to inform sample size calculations and study procedures for a future definitive trial. All analyses will be run using freely or commercially available software (R or SPSS statistics) by the applicant in collaboration with supervisors of the PhD-project. The sample size is based on recommendations for feasibility and pilot studies, recommending a sample size of 30 participants to establish feasibility.

2.1.6 Qualitative analysis plan

Using the NVivo software, qualitative data will be analyzed using thematic analysis to explore therapists' and users' experiences with the Sidekick app. Initial coding will capture key concepts, which will then be grouped into broader themes reflecting the core experiences of both therapists and adolescents. This process will highlight perceptions of the app, including its strengths and areas for improvement. Comparative analysis will contrast the themes from both perspectives to provide a comprehensive understanding of the app's impact and effectiveness in outpatient treatment. The findings will inform app enhancements and implementation strategies to better support therapists and adolescents in these settings.

03

Conditions studied

  • Anxiety Disorders

Browse trials for

Keywords

  • anxiety disorders
  • digital interventions
  • digital cognitive behavioral therapy
  • digital ad-on
  • digital adjunct
  • adolescents
  • feasibility trial
  • exposure therapy
  • mobile app
04

Who can participate

Ages eligible
13 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 13 to 18 years old
  • Adequate Norwegian reading, writing and speaking skills
  • Access to the internett and a smart-phone
  • Diagnosed anxiety disorder
  • Receiving outpatient treatment for their anxiety disorder
  • Exposure therapy included in therapy during the study period
  • Therapist agrees to incorporate the app as an ad-on to therapy
  • For patients receiving medication, inclusion requires a stable dose of medication for a psychiatric disorder for six weeks

Exclusion criteria

Exclusion Criteria:

  • Participants with serious mental illness, such as suicidality or poor general functioning may be excluded if participation is considered unfeasible or potentially harmful. Decision will be based on collaborative evaluation by the participants therapist and the research-team.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
46 participants (estimated)

Study arms

  • Experimental
    Sidekick

    Use of the Sidekick app as an ad-on to regular outpatient treatment.

    Device: Sidekick

Interventions

  • DeviceSidekick

    An app for adolescents used to plan, complete and evaluate exposure exercises completed between sessions at a children and adolescent mental health clinic (BUP)

    Also known as: App-facilitated exposure therapy, Digital cognitive behavioral therapy, Digital adjunct, Digital ad-on

06

What researchers measure

Primary outcomes

  1. Sidekick app engagement and completion of tasks

    Sidekick app engagement and completion of tasks will be evaluated through assessment of user-data from the app.

    Time frame: From pre-treatment/baseline to post-treatment (variable and participant-dependent, estimated range: 4-12 weeks)

  2. Credibility and Expectancy Questionnaire (CEQ-1)

    The Credibility and Expectancy Questionnaire (CEQ-1) is a 1-item self-report questionnaire used to assess treatment credibility and treatment expectancy. Minimum score: 1. Maximum score: 9. Higher scores mean better outcomes.

    Time frame: At post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline)

  3. Client Satisfaction Questionnaire (CSQ-3)

    The Client Satisfaction Questionnaire (CSQ-3) is a 3-item self-report measure used clients satisfaction with a service. Minimum score: 1. Maximum score: 4. Higher scores mean better outcomes.

    Time frame: At post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline)

  4. EuroQoL 5D-5L (EQ-5D-5L)

    EuroQoL 5D-5L (EQ-5D-5L) is a self-report questionnaire assessing health-related quality of life and cost-effectiveness analysis. It assesses health on five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Question 1-25: Minimum score: 1. Maximum score: 5. Higher scores mean worse outcomes. Question 26: Minimum score: 0. Maximum score: 100. Higher scores mean better outcomes.

    Time frame: At pre-treatment/baseline and post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline)

  5. Level of anxiety before, during and after exposure tasks

    Participants will evaluate their level of anxiety on a sliding bar in the Sidekick app before, during and after every exposure task completed. User-data from the Sidekick app will be collected. Minimum score: 1. Maximum score: 10. Higher scores mean worse outcomes.

    Time frame: From pre-treatment/baseline to post-treatment (variable and participant-dependent, estimated range: 4-12 weeks) after every completed exposure task (variable and participant-dependent, estimated range: 1-20 exposure tasks per month)

  6. Recruitment

    The investigators will assess recruitment capability and sample characteristics and provide a flow-chart to evaluate feasibility of completing the planned study.

    Time frame: At pre-treatment/baseline.

  7. Adherence

    The investigators will assess retention and follow-up rates, and adherence to procedures to evaluate feasibility of completing the planned study.

    Time frame: From pre-treatment/baseline to post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline), and from post-treatment to 3-month follow-up.

  8. Qualitative interviews

    To evaluate user experiences from both patients and clinicians perspectives taking part in the study.

    Time frame: At post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline).

  9. Revised Child Anxiety and Depression Scale (RCADS 47)

    The Revised Child Anxiety and Depression Scale (RCADS) is a self-report measure of anxiety symptoms for children and adolescents aged 8-18 years old. It has 47 items, and results in subscales of separation anxiety, social phobia, generalized anxiety disorder, panic disorder, obsessive compulsive disorder and major depressive disorder. The scale provides a total anxiety scale (sum of the 5 anxiety subscales) and a total internalizing scale (sum of all 6 subscales). Minimum score: 10 Maximum score: 3. Higher scores mean worse outcomes.

    Time frame: At pre-treatment/baseline, post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline), and 3-month follow-up.

  10. General self-efficacy scale (GSES)

    The General self-efficacy scale (GSES) is a 10-item self-report questionnaire used to measure the respondents perceived self-efficacy. Minimum score: 1. Maximum score: 4. Higher scores mean better outcomes.

    Time frame: At pre-treatment/baseline, post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline), and 3-month follow-up.

  11. KIDSCREEN-10

    KIDSCREEN-10 is a 10-item self-report questionnaire for children and adolescents aged 8-18 years old. It measures general health-related quality of life (HRQoL). Minimum score: 1. Maximum score: 5. Higher scores mean better outcomes.

    Time frame: At pre-treatment/baseline, post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline), and 3-month follow-up.

  12. Patient Exposure and Response Prevention Adherence Scale (PEAS)

    The Patient Exposure and Response Prevention Adherence Scale (PEAS) is a 3-item self-report questionnaire designed to measure adherence of exposure and response prevention outside of therapy sessions. Minimum score: 0. Maximum score: 7. Higher scores mean better outcomes.

    Time frame: From pre-treatment/baseline to post-treatment (variable and participant-dependent, estimated range: 4-12 weeks) after every completed exposure task (variable and participant-dependent, estimated range: 1-20 exposure tasks per month)

07

Study locations

1 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Apr 2027, 18 months after the start.

Of 3,871 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 18 months is above that.

Counting every sponsor, half of 3,976 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion Oct 2026 → Apr 2027 and completion Mar 2027 → Apr 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 5, 2025
First posted
Aug 28, 2025
StartActual
Oct 20, 2025
Primary completionEst.
Apr 2027was Oct 2026
CompletionEst.
Apr 2027was Mar 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Oct 2026→Apr 2027
Nov 18, 2026
Study completion
Mar 2027→Apr 2027
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Primary completion Oct 2026→Apr 2027
    Study completion Mar 2027→Apr 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07145307
Lead sponsor
Helse Stavanger HF
Collaborators
Alcohol and Drug Research Western Norway (KoRFor), Research Centre for Digital Mental Health Services (Forhelse)
Responsible party
Pia Rygg Hauge (Principal Investigator, Helse Stavanger HF) — Principal investigator
First posted
Aug 28, 2025
Start date
Oct 20, 2025
Primary completion
Apr 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Pia R Hauge, Master
Contact
pia.rygg.hauge@sus.no
+47 92877830
Aleksander H Erga, PhD
Contact
aleksander.hagen.erga@sus.no
+4751515684
Aleksander H Erga, PhD
study director · KORFOR, Helse Stavanger
Torgeir G Lid, PhD
study chair · KORFOR, Helse Stavanger
Emilie S Nordby, PhD
study chair · Forhelse, Helse Bergen
Tine Nordgreen, PhD
study chair · Forhelse, Helse Bergen
Pia R Hauge, Master
principal investigator · Helse Stavanger HF

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion